Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002019410-25-000028
Filing Date
2025-11-05
Accepted
2025-11-05 17:01:37
Documents
84
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cai-20250930.htm   iXBRL 10-Q 2517734
2 EX-10.1 exh1013rdamendmentleaseagr.htm EX-10.1 57492
3 EX-31.1 ex311-302certificationceo.htm EX-31.1 10133
4 EX-31.2 ex312-302certificationcfo.htm EX-31.2 10143
5 EX-32.1 ex321-906certificationceo.htm EX-32.1 5189
6 EX-32.2 ex322-906certificationcfo.htm EX-32.2 5349
  Complete submission text file 0002019410-25-000028.txt   11214867

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cai-20250930.xsd EX-101.SCH 64561
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cai-20250930_cal.xml EX-101.CAL 71915
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cai-20250930_def.xml EX-101.DEF 494813
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cai-20250930_lab.xml EX-101.LAB 822381
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cai-20250930_pre.xml EX-101.PRE 647678
87 EXTRACTED XBRL INSTANCE DOCUMENT cai-20250930_htm.xml XML 1487858
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42706 | Film No.: 251454949
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)